Isoxazole derivatives and their use as metabotropic glutamate receptor potentiators

Details for Australian Patent Application No. 2009255784 (hide)

Owner AstraZeneca AB

Inventors Folmer, James; Hunter, Angela M.; Empfield, James; Cacciola, Joseph; Throner, Scott

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2009255784

PCT Pub. Number WO2009/148403

Priority 61/059,485 06.06.08 US

Filing date 8 June 2009

Wipo publication date 10 December 2009

Acceptance publication date 16 August 2012

International Classifications

C07D 413/10 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/422 - not condensed and containing further heterocyclic rings

A61P 25/00 Drugs for disorders of the nervous system

C07D 209/46 Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

Event Publications

16 December 2010 PCT application entered the National Phase

  PCT publication WO2009/148403 Priority application(s): WO2009/148403

16 August 2012 Application Accepted

  Published as AU-B-2009255784

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009255792-Hook removal tool

2009255777-Concentration assay